97069 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Blood coagulation or fibrinolysis factors Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
GENE THERAPY FOR TREATING WILSON'S DISEASE
#2HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#3FACTOR VIII POLYPEPTIDE FORMULATIONS
#4VARIANTS OF COAGULATION FACTOR VIII AND USES THEREOF
#5HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#6METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES
#7HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#8HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#9COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS
#10MEANS AND METHODS FOR AAV GENE THERAPY IN HUMANS
#11PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#12Adeno-Associated Virus Factor VIII Vectors
#13LINKER PEPTIDE, FVIII PROTEIN OR VARIANT THEREOF CONTAINING LINKER PEPTIDE, AND USE THEREOF
#14FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
#15NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS
#16CODON-OPTIMIZED NUCLEIC ACID ENCODING THE FVIII-BDD
#17THERAPEUTIC ADENO-ASSOCIATED VIRUS USING CODON OPTIMIZED NUCLEIC ACID ENCODING FACTOR VIII
#18NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY
#19COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION
#20IMPLANTABLE PARTICLES AND RELATED METHODS
#21TISSUE-SPECIFIC PROMOTER AND USE THEREOF
#22HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#23PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS
#24FACTOR VIII CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF
#25RECOMBINANT HUMAN SERUM ALBUMIN-COLLAGEN BINDING DOMAIN FUSION PROTEIN FOR TUMOR-SPECIFIC TARGETING MATRIX, AND USE THEREOF
#26NUCLEIC ACID MOLECULES AND USES THEREOF
#27CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
#28ON-COLUMN VIRAL INACTIVATION METHODS
#29ENGINEERED LIVER-SPECIFIC ENHANCERS AND THEIR APPLICATIONS
#30OPTIMIZED HUMAN CLOTTING FACTOR VIII GENE EXPRESSION CASSETTES AND THEIR USE
#31Factor VIII Sequences
#32ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS OF USE THEREOF
#33METHODS OF TREATING HEMOPHILIA A
#34HIGHLY SOLUBLE FIBRINOGEN COMPOSITIONS
#35SCALABLE AND HIGH-PURITY CELL-FREE SYNTHESIS OF CLOSED-ENDED DNA VECTORS
#36GENE THERAPY OF HEMOPHILIA A USING VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION
#37von Willebrand Factor Proteins for Treating Bleeding Disorders
#38ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A
#39NOVEL POLYPEPTIDES AND MEDICAL USES THEREOF
#40METHODS OF TREATING HEMOPHILIA A
#41LIVER-SPECIFIC EXPRESSION CASSETTES, VECTORS AND USES THEREOF FOR EXPRESSING THERAPEUTIC PROTEINS
#42NUCLEIC ACIDS ENCODING FACTOR VIII POLYPEPTIDES WITH REDUCED IMMUNOGENICITY
#43ENGINEERED ITR SEQUENCES AND METHODS OF USE
#44ISOLATED NUCLEIC ACID MOLECULE AND USE THEREOF
#45FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
#46PLATELET TARGETED TREATMENT
#47Engineered Human FVIII with Enhanced Secretion Ability and Clotting Activity
#48RECOMBINANT COAGULATION FACTOR VIII AND USE THEREOF
#49POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF
#50SYNTHETIC AAV VECTORS FOR REPEATED DELIVERY OF THERAPEUTIC GENES
#51STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS
#52COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A
#53MODIFIED PLASMA CLOTTING FACTOR VIII AND METHOD OF USE THEREOF
#54OPTIMIZED FACTOR VIII GENE
#55OPTIMIZED FACTOR VIII GENES
#56LINKER PEPTIDE FOR CONSTRUCTING FUSION PROTEIN
#57THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF
#58IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA
#59Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the Same
#60PLATELET ALPHA-GRANULES FOR DELIVERY OF MULTIPLE PROTEINS
#61Polypeptides and medical uses thereof
#62De-immunized factor VIII molecule and pharmaceutical compositions comprising the same
#63Preparation of therapeutic exosomes using membrane proteins
#64TISSUE ORGANOIDS
#65NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS
#66METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES
#67COMPOUND FOR INCREASING THE EFFICACY OF FACTOR VIII REPLACEMENT THERAPY
#68NUCLEIC ACID AND AMINO ACID SEQUENCES ENCODING HIGH-LEVEL EXPRESSOR FACTOR VIII POLYPEPTIDES AND METHODS OF USE
#69RECOMBINANT FACTOR VIII VARIANTS
#70On-column viral inactivation methods
#71RECOMBINANT FACTOR VIII PROTEINS
#72FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#73INTEGRATION OF LARGE ADENOVIRUS PAYLOADS
#74REGULATORY T CELL EPITOPES
#75Factor VIII Sequences
#76ANTI-VWF D'D3 SINGLE-DOMAIN ANTIBODIES AND POLYPEPTIDES COMPRISING THEREOF
#77SUBCUTANEOUS ADMINISTRATION OF FACTOR VIII
#78Factor VIII zwitterionic polymer conjugates
#79COMPOSITIONS AND METHODS OF TREATMENT FOR VASCULAR DISEASES AND THROMBOSIS
#80RECOMBINANT SINGLE-CHAIN FVIII AND CHEMICAL CONJUGATE THEREOF
#81METHOD FOR EFFICIENTLY SEPARATING AND PURIFYING RECOMBINANT HUMAN COAGULATE FACTOR VIII FC FUSION PROTEIN
#82LIVER-SPECIFIC CONSTRUCTS, FACTOR VIII EXPRESSION CASSETTES AND METHODS OF USE THEREOF
#83CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES
#84Chromatographic methods for purification of proteins from plasma
#85OPTIMIZED FACTOR VIII GENES
#86Adeno-Associated Viral (AAV) Vectors for Tissue-Targeted Expression of Therapeutic Genes
#87LIVER-SPECIFIC PROMOTER AND APPLICATION THEREOF
#88IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
#89FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#90METHOD FOR CONTINUOUS PROTEIN RECOVERING
#91CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF
#92METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
#93ENGINEERED CELLS FOR CONTROLLED PRODUCTION
#94COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION
#95FACTOR VIII CONSTRUCT
#96FACTOR VIII POLYPEPTIDE
#97Means and methods for AAV gene therapy in humans
#98GENE THERAPY FOR TREATING WILSON'S DISEASE
#99A TRUNCATED VON WILLEBRAND FACTOR (VWF) FOR INCREASING THE IN VITRO STABILITY OF COAGULATION FACTOR VIII
#100Optimized promoter sequences, intron-free expression constructs and methods of use
#101POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII
#102Adeno-associated virus factor VIII vectors
#103Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression
#104Modified plasma clotting factor VIII and method of use thereof
#105Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications
#106Purification of Factor VIII subspecies
#107FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
#108FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF
#109SINGLE CHAIN FACTOR VIII MOLECULE
#110ENGINEERED ITR SEQUENCES AND METHODS OF USE
#111SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL DNA VECTORS
#112COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS
#113ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF
#114VIRAL VECTORS ENCODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA A
#115METHOD FOR PURIFICATION OF PLASMA PROTEINS
#116ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A
#117NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FVIII THERAPEUTICS
#118METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#119MUTANT FACTOR VIII COMPOSITIONS AND METHODS
#120THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF
#121PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#122Linker peptide for constructing fusion protein
#123MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA)
#124RED BLOOD CELL TARGETED FACTOR VIII AND METHOD OF USING THE SAME
#125COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A
#126FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF
#127SEPARATION OF VWF AND VWF PROPEPTIDE BY CHROMATOGRAPHIC METHODS
#128FUSION PROTEIN OF MUTATED SINGLE-CHAIN HUMAN COAGULATION FACTOR VIII, PREPARATION METHOD THEREFOR, AND USE THEREOF
#129Compositions and methods for modulating Factor VIII function
#130STRUCTURE-SENSITIVE PEPTIDE ANTIGEN OF VON WILLEBRAND FACTOR
#131Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#132EXPOSED COLLAGEN-TARGETED FUSION CYTOKINE FOR IMMUNE MODULATION IN INVASIVE CANCERS AND LESIONS OF INFECTIONS
#133IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS
#134BI-FUNCTIONAL ARGININE-GLYCINE-ASPARTIC ACID (RGD) PEPTIDES AND METHODS TO PROMOTE ANGIOGENESIS
#135Polypeptides and medical uses thereof
#136Factor VIII proteins having ancestral sequences, expression vectors, and uses related thereto
#137New Tools for Improving Gene Therapy and Use Thereof
#138Optimized Liver-Specific Expression Systems for FVIII and FIX
#139CHIMERIC CLOTTING FACTORS
#140MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT CELLS
#141ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#142COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES
#143Modified FVIII Apitope Peptides
#144In vivo protein N-acylation
#145Method for improving the stability of purified Factor VIII after reconstitution
#146REGULATORY T CELL EPITOPES
#147PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME
#148HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#149COAGULATION FACTOR VIII MIMETIC PROTEIN AND USES THEREOF
#150METHOD OF PURIFYING THERAPEUTIC PROTEINS
#151Polypeptides modulating SIGLEC dependent immune responses
#152PURIFICATION OF CHIMERIC FVIII MOLECULES
#153Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
#154COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A
#155Nucleic acid molecules and uses thereof
#156FACTOR VIII MUTANT EXPRESSION VECTOR WITH ENHANCED PROTEIN EXPRESSION
#157NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE
#158Implantable particles and related methods
#159COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA
#160MODIFIED AAV CAPSIDS AND USES THEREOF
#161RECOMBINANT PROMOTERS AND VECTORS FOR PROTEIN EXPRESSION IN LIVER AND USE THEREOF
#162Methods for preparing modified von Willebrand Factor
#163Method of producing recombinant high molecular weight vWF in cell culture
#164METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES
#165IN-VIVO RELEASE SUSTAINED RECOMBINANT COAGULATION FACTOR VIII AND PREPARATION METHOD THEREFOR
#166FACTOR VIII POLYPEPTIDE FORMULATIONS
#167Nucleic acids encoding clotting factor variants and their use
#168Optimised coding sequence and promoter
#169Polypeptides and medical uses thereof
#170MUTEINS OF CLOTTING FACTOR Vlll
#171Factor VIII sequences
#172RECOMBINANT ADIPOSE-DERIVED STEM CELL EXPRESSING BDDHFVIII GENE, AND PREPARATION METHOD AND APPLICATION THEREOF
#173Methods for preparing modified von Willebrand factor
#174IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA
#175POST-NATAL TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA
#176Von Willebrand factor proteins for treating bleeding disorders
#177Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof
#178HARNESSING PROTEIN-BASED DRUGS COMPRISING AN ANCHOR DOMAIN FOR USE ON THE OCULAR SURFACE
#179METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#180Treatment of monogenetic disorders
#181Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
#182METHODS AND COMPOSITIONS RELATED TO LONG HALF-LIFE COAGULATION COMPLEXES
#183ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#184On-column viral inactivation methods
#185Anti-coagulation factor VIII antibody and use thereof
#186Factor VIII proteins having ancestral sequences, expression vectors, and uses related thereto
#187COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS
#188Method for improving the stability of purified Factor VIII after reconstitution
#189COMPOSITION FOR TREATING HEMOPHILIA A BY CRISPR/CAS SYSTEM OF REVERTING FVIII GENE INVERSION
#190METHODS, COMPOSITIONS, AND IMPLANTABLE ELEMENTS COMPRISING ACTIVE CELLS
#191Factor VIII zwitterionic polymer conjugates
#192Preparation of therapeutic exosomes using membrane proteins
#193Anti-VWF D'D3 single-domain antibodies fuse to clotting factors
#194METHOD FOR VIRUS FILTRATION OF VON WILLEBRAND FACTOR
#195STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS
#196ENDOTHELIAL-SPECIFIC PROMOTER SEQUENCES AND USES THEREOF
#197Truncated VWF
#198TISSUE ORGANOIDS
#199Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies
#200ANTI-GPIIB/IIIA ANTIBODIES OR USES THEREOF
#201Adeno-associated virus factor VIII vectors
#202PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#203FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#204Immunoglobulin chimeric monomer-dimer hybrids
#205NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY
#206In vivo protein N-acylation
#207Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
#208Recombinant factor VIII proteins
#209Optimized factor VIII gene
#210NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE
#211Method of separating Factor VIII from blood products
#212Separation of VWF and VWF propeptide by chromatographic methods
#213Methods of treating hemophilia A
#214Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of same
#215POPULATION PHARMACOKINETICS TOOLS AND USES THEREOF
#216Red blood cell targeted factor VIII and method of using the same
#217Factor VIII mutation repair and tolerance induction
#218Gene therapy for treating Wilson's disease
#219Chimera protein comprising FVIII and vWF factors, and use thereof
#220FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#221Blood coagulation protein conjugates
#222Optimized human clotting factor VIII gene expression cassettes and their use
#223Allelic variants of human factor VIII
#224Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#225SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTORS PRODUCED THEREBY
#226PLATELET TARGETED TREATMENT
#227Promoter for cell-specific gene expression and uses thereof
#228Truncated von Willebrand Factor polypeptides for treating hemophilia
#229Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
#230Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
#231Cell-associated secretion-enhancing fusion proteins
#232Biologically active peptides
#233Protein stabilizing factors
#234Hydrophobic charge induction chromatographic protein depleted solution
#235Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
#236Polypeptides modulating SIGLEC dependent immune responses
#237Codon optimization for increasing transgene expression in chloroplasts of higher seed plants
#238Mammalian cell culture-produced neublastin antibodies
#239Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
#240Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients
#241Polypeptide substrate for the detection of von Williebrand factor cleaving protease ADAMTS13
#242Optimized factor VIII genes
#243Linker peptide for constructing fusion protein
#244Mutant factor VIII compositions and methods
#245Glycosylated VWF fusion proteins with improved pharmacokinetics
#246Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof
#247COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS
#248Liver-specific constructs factor VIII expression cassettes and methods of use thereof
#249FACTOR VIII VARIANTS, NUCLEIC ACID SEQUENCES, AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
#250Engineered nucleases useful for treatment of hemophilia A
#251Liver-specific constructs and methods of use thereof
#252Preparation of therapeutic exosomes using membrane proteins
#253Anti-VWF D'D3 single-domain antibodies and methods of use
#254Method of producing recombinant high molecular weight vWF in cell culture
#255Purification of factor VIII subspecies
#256Preparation of therapeutic exosomes using membrane proteins
#257Production of oversized adeno-associated vectors
#258Method for improving the stability of purified factor VIII after reconstitution
#259STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS
#260Polypeptides and medical uses thereof
#261Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#262Mutated von Willebrand factor
#263Mutated truncated von Willebrand Factor
#264CELL LINE EXPRESSING SINGLE CHAIN FACTOR VIII POLYPEPTIDES AND USES THEREOF
#265Means and methods for AAV gene therapy in humans
#266Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
#267Recombinant promoters and vectors for protein expression in liver and use thereof
#268Variant serum albumin with improved half-life and other properties
#269Factor VIII variants having a decreased cellular uptake
#270Method for the production of freeze-dried pellets comprising factor VIII
#271Processable single chain molecules and polypeptides made using same
#272CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERS
#273Method of treating hemophilia A
#274DNA aptamer that binds to vWF
#275MODIFIED BLOOD CLOTTING FACTORS AND METHODS OF USE
#276Methods and compositions related to long half-life coagulation complexes
#277Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections
#278METHODS FOR USE OF MIXED MULTIFUNCTIONAL SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS
#279Glycopolysialylation of non-blood coagulation proteins
#280EFFICIENT PRODUCTION OF PEPTIDES
#281Factor VIII protein compositions and methods of treating of hemophilia A
#282Preparation comprising factor VIII and Von Willebrand factor peptides
#283Compounds Suitable for Treatment of Haemophilia
#284ADENO-ASSOCIATED VIRUS FACTOR VIII VECTORS
#285Methods for preparing modified von Willebrand factor
#286Variant factor VIII polypeptides and methods of their production and use
#287Chromatographic methods for purification of proteins from plasma
#288Method for chromatography
#289Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis
#290COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSITIONS, AND USES RELATING THERETO
#291PROTEIN EXPRESSION ENHANCING POLYPEPTIDES
#292METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#293Optimized liver-specific expression systems for FVIII and FIX
#294RNA guided endonuclease targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same
#295Talen targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising same
#296Modified von Willebrand factor having improved half-life
#297Method of producing recombinant high molecular weight vWF in cell culture
#298COMPOUNDS FOR IMPROVING THE HALF-LIFE OF VON WILLEBRAND FACTOR
#299Endonuclease targeting blood coagulation factor VIII gene and composition for treating hemophilia comprising same
#300FORMULATIONS AND METHODS FOR INCREASED RECOMBINANT PROTEIN PRODUCTION